ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

9 links0 made here, not in the record16 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07453394QLS5132 Combination Therapyin Advanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/Phase 2 · not yet recrRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSStomach NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termEndometrial NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSQLS5132Entry “QLS5132; Bevacizumab”, read by…›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBevacizumabEntry “QLS5132; Bevacizumab”, read by…›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPlatinum CompoundsEntry “QLS5132; Platinum; Bevacizumab…›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOlaparibEntry “QLS5132; Olaparib; Bevacizumab…›Nov 1 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · TestedTestedQL2107Entry “QLS5132; QL1706; QL2107”, read…›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

QLS5132

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “QLS5132; Bevacizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1QLS5132Claude Opus 5.5TestedCurrent
Nov 1BevacizumabClaude Opus 5.5TestedCurrent
Nov 1Platinum CompoundsClaude Opus 5.5TestedCurrent
Nov 1OlaparibClaude Opus 5.5TestedReplaced
Nov 1QL2107Claude Opus 5.5BackgroundCurrent
Nov 3OlaparibClaude Opus 5.5Background · partnerCurrent
Nov 14Stomach NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Endometrial NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Ovarian NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 18QLS5132Rule based · role ruleTestedAgrees
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18Platinum CompoundsRule based · role ruleTestedAgrees
Nov 18OlaparibRule based · role ruleTestedCurrent
Nov 18QL2107Rule based · role ruleTestedCurrent
As of nowStomach NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.